Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Editorials
Healthcare: No Value Without Equity
The Innovation and Value Initiative (IVI) recently published a data brief focused on health equity following a series of…
Numerof & Associates Releases Seventh Annual Numerof Survey Report
In November 2022, Numerof & Associates released the State of Population Health: Seventh Annual Numerof Survey Report.…
Who Does the 340B Program Benefit?
Recently, Robert Popovian and Peter J. Pitts authored an editorial for the Food and Drug Law Institute, “340B and the Warped…
Practical Strategies to Promote Diversity, Equity, and Inclusion in…
On August 25, 2022, Blood Advances published a new study, authored by Ruemu Birhiray, MD and his daughter, Maya Birhiray, BS, that…
Analysis of Drug Formulary Exclusions from the Patient’s Perspective
Earlier this year, Robert Popovian, Pharm.D.; Anne M. Sydor, Ph.D.; and Peter Pitts conducted an analysis of drug formulary…
Translating Clinical Research to Clinical Care in Nephrology
Recently, CMEology conducted a study of nephrologists to identify factors that are influential in the translation of research…
Opinion Editorial: Why Should We Rescue The Legislative Intent Of The…
By Peter J. Pitts, Robert Popovian, and Wayne Winegarden
What happens when regulatory ambiguity displaces sound…
Editorial: The US Drug Pricing System Needs to Be Fixed
By Robert Popovian, Pharm.D., MS, and Wayne Winegarden, Ph.D.
Reforms to the U.S. drug pricing environment are required, but to…
Pharmacists Can Help Get COVID-19 Vaccines in Arms
The below story was originally published in the Washington Times here and was written by Rick Gates, Rich Tremonte, and Robert…
Editorial Outlines Four Potential Paths the Biden Administration Should…
Recently, Robert Popovian, Pharm.D., MS., and Wayne Winegarden, Ph.D., wrote an opinion piece for Morning Consult, advocating for…